The Journal of Minimally Invasive Gynecology
Volume 17, Issue 1 , Pages 59-65, January 2010

Hysteroscopic Management of Large Symptomatic Submucous Uterine Myomas

  • M. Camanni, MD

      Affiliations

    • GINTEAM Unit of Minimally Invasive Gynaecology, University of Turin, Turin, Italy
    • ,
  • Luca Bonino, MD

      Affiliations

    • GINTEAM Unit of Minimally Invasive Gynaecology, University of Turin, Turin, Italy
    • Corresponding Author InformationCorresponding author: Luca Bonino, MD, Corso Marconi 35, 10125 Turin, Italy.
    • ,
  • E.M. Delpiano, MD

      Affiliations

    • GINTEAM Unit of Minimally Invasive Gynaecology, University of Turin, Turin, Italy
    • ,
  • B. Ferrero, MD

      Affiliations

    • GINTEAM Unit of Minimally Invasive Gynaecology, University of Turin, Turin, Italy
    • ,
  • G. Migliaretti, MD

      Affiliations

    • Department of Public Health and Microbiology, University of Turin, Turin, Italy
    • ,
  • F. Deltetto, MD

      Affiliations

    • GINTEAM Unit of Minimally Invasive Gynaecology, University of Turin, Turin, Italy

Received 14 July 2009; accepted 29 October 2009.

Abstract 

Study Objective

To evaluate the feasibility of hysteroscopic resection of large submucous uterine myomas.

Design

Prospective study (Canadian Task Force classification II-3).

Setting

Surgery unit of minimally invasive gynecology.

Patients

Thirty-three women with submucous myomas 5 cm or larger in diameter with menorrhagia, dysmenorrhea, or infertility.

Intervention

Hysteroscopic myomectomy.

Measurements and Main Results

Satisfaction with the surgery and an improvement in symptoms were the primary outcomes. Possibility of 1-step resection; complication rate, and disease recurrence were also considered. Menorrhagia was the most frequent indication (91%). According to the Wamsteker classification, 84.8% were type II myomas, whereas 93.9% scored 5 or higher according to the classification of Lasmar and colleagues. Mean operating time was 50 minutes (interquartile range, 35–65). One-step excision was achieved in 81.8% of patients. Of 5 women with incomplete resection, 3 needed a second surgery, and 2 were symptom-free. Patients with myomas larger than 5 cm or with a Lasmar score higher than 7 were more likely to undergo a 2-step procedure. In patients with myomas larger than 6 cm, recovery time was significantly longer than in those with smaller myomas. We recorded 3 complications: intravasation, uterine perforation, and postoperative anemia, in 1 patient each; at present, all 3 women are symptom-free. Median (range) follow-up was 10 (6–22) months. Twenty-seven patients (81.2%) reported they were very satisfied; 5 patients (15.2%) were satisfied; and 1 patient (3%) was dissatisfied.

Conclusions

Hysteroscopic myomectomy can be the treatment of choice in symptomatic patients with a submucous myoma with diameter of 6 cm or less. Although this technique raises the possibility that complete resection may require 2 surgical sessions, it is a feasible surgical procedure. However, for myomas 6 cm or larger in diameter, this approach is less attractive. Nevertheless, we believe that all of the limiting criteria defined in the available literature should be evaluated individually, bearing in mind each patient's particular condition and the surgeon's experience and skill.

Keywords: Hysteroscopic myomectomy, Hysteroscopy, Submucous myoma

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 The authors have no commercial, proprietary, or financial interest in the products or companies described in this article.

PII: S1553-4650(09)01238-2

doi:10.1016/j.jmig.2009.10.013

The Journal of Minimally Invasive Gynecology
Volume 17, Issue 1 , Pages 59-65, January 2010

Article Tools